{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:15:49Z","timestamp":1790100949500,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,19]]},"DOI":"10.7759\/cureus.37813","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:24:14Z","timestamp":1681896254000},"source":"Crossref","is-referenced-by-count":6,"title":["Effect of Discontinuation of Renin Angiotensin-System Inhibitors in Patients With Advanced Chronic Kidney Disease: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Husnain","family":"Naveed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Tirumandyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham Varun","family":"Krishna Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawara","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alveena","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoilo K","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh J","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, et al.. Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298:2038-47. 10.1001\/jama.298.17.2038","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-2-200407200-00007","article-title":"The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency","volume":"141","author":"Hsu CY","year":"2004","unstructured":"Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med. 2004, 141:95-101. 10.7326\/0003-4819-141-2-200407200-00007","journal-title":"Ann Intern Med"},{"key":"ref3","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease..  Kidney Int Suppl. 2013, 3:1-150.","journal-title":"Kidney Int Suppl"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha V","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, et al.. Chronic kidney disease: global dimension and perspectives. Lancet. 2013, 382:260-272. 10.1016\/S0140-6736(13)60687-X","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis EJ","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, et al.. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001, 345:851-60. 10.1056\/NEJMoa011303","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa LY","year":"2001","unstructured":"Agodoa LY, Appel L, Bakris GL, et al.. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001, 285:2719-28. 10.1001\/jama.285.21.2719","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200110000-00023","article-title":"A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease","volume":"19","author":"Marin R","year":"2001","unstructured":"Marin R, Ruilope LM, Aljama P, Aranda P, Segura J, Diez J. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease. J Hypertens. 2001, 19:1871-6. 10.1097\/00004872-200110000-00023","journal-title":"J Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2016. 11.005","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"69","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol. 2016, 69:1167. 10.1016\/j.rec.2016. 11.005","journal-title":"Rev Esp Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000013599","article-title":"Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors","volume":"20","author":"Ahuja TS","year":"2000","unstructured":"Ahuja TS, Freeman D Jr, Mahnken JD, Agraharkar M, Siddiqui M, Memon A. Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors. Am J Nephrol. 2000, 20:268-72. 10.1159\/000013599","journal-title":"Am J Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita K","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, et al.. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375:2073-81. 10.1016\/S0140-6736(10)60674-5","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.06.010","article-title":"Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report","volume":"72","author":"Weir MR","year":"2018","unstructured":"Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E. Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report. Am J Kidney Dis. 2018, 72:873-84. 10.1053\/j.ajkd.2018.06.010","journal-title":"Am J Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019)","volume":"42","author":"Umemura S","year":"2019","unstructured":"Umemura S, Arima H, Arima S, et al.. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019, 42:1235-481. 10.1038\/s41440-019-0284-9","journal-title":"Hypertens Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210639","article-title":"Renin-angiotensin system inhibition in advanced chronic kidney disease","volume":"387","author":"Bhandari S","year":"2022","unstructured":"Bhandari S, Mehta S, Khwaja A, et al.. Renin-angiotensin system inhibition in advanced chronic kidney disease. N Engl J Med. 2022, 387:2021-32. 10.1056\/NEJMoa2210639","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020050682","article-title":"Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study","volume":"32","author":"Fu EL","year":"2021","unstructured":"Fu EL, Evans M, Clase CM, Tomlinson LA, van Diepen M, Dekker FW, Carrero JJ. Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study. J Am Soc Nephrol. 2021, 32:424-35. 10.1681\/ASN.2020050682","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0193","article-title":"Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate","volume":"180","author":"Qiao Y","year":"2020","unstructured":"Qiao Y, Shin JI, Chen TK, et al.. Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate. JAMA Intern Med. 2020, 180:718-26. 10.1001\/jamainternmed.2020.0193","journal-title":"JAMA Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101751","article-title":"Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study","volume":"55","author":"Yang A","year":"2023","unstructured":"Yang A, Shi M, Lau ES, et al.. Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study. EClinicalMedicine. 2023, 55:101751. 10.1016\/j.eclinm.2022.101751","journal-title":"EClinicalMedicine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie X","year":"2016","unstructured":"Xie X, Liu Y, Perkovic V, et al.. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016, 67:728-41. 10.1053\/j.ajkd.2015.10.011","journal-title":"Am J Kidney Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar MZ","year":"2014","unstructured":"Molnar MZ, Kalantar-Zadeh K, Lott EH, et al.. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol. 2014, 63:650-8. 10.1016\/j.jacc.2013.10.050","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000146423.71226.0C","article-title":"Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results","volume":"15","author":"Remuzzi G","year":"2004","unstructured":"Remuzzi G, Ruggenenti P, Perna A, et al.. Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results. J Am Soc Nephrol. 2004, 15:3117-25. 10.1097\/01.ASN.0000146423.71226.0C","journal-title":"J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril efficacy in nephropathy","volume":"12","author":"Ruggenenti P","year":"2001","unstructured":"Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril efficacy in nephropathy. J Am Soc Nephrol. 2001, 12:2832-7. 10.1681\/ASN.V12122832","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-00877-5","article-title":"Effects of renin-angiotensin system inhibitors on the incidence of unplanned dialysis","volume":"45","author":"Nakayama T","year":"2022","unstructured":"Nakayama T, Morimoto K, Uchiyama K, et al.. Effects of renin-angiotensin system inhibitors on the incidence of unplanned dialysis. Hypertens Res. 2022, 45:1018-27. 10.1038\/s41440-022-00877-5","journal-title":"Hypertens Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-00902-7","article-title":"Role of renin-angiotensin system blockade in advanced CKD: to use or not to use?","volume":"45","author":"Mukoyama M","year":"2022","unstructured":"Mukoyama M, Kuwabara T. Role of renin-angiotensin system blockade in advanced CKD: to use or not to use?. Hypertens Res. 2022, 45:1072-5. 10.1038\/s41440-022-00902-7","journal-title":"Hypertens Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/147383-effect-of-discontinuation-of-renin-angiotensin-system-inhibitors-in-patients-with-advanced-chronic-kidney-disease-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:10Z","timestamp":1707508810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/147383-effect-of-discontinuation-of-renin-angiotensin-system-inhibitors-in-patients-with-advanced-chronic-kidney-disease-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.37813","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}